Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients.

Auteurs : Plouznikoff N, Artigas C, Sideris S, Martinez Chanza N, Gil T, Peltier A, Flamen P
Année : 2019
Journal : Ann Nucl Med
Volume : 33
Pages : 945-954